Bio Vitos Pharma
0.386
SEK
-19.42 %
BIOVIT
First North Stockholm
Medical Equipment & Services
Health Care
Be the first to follow this company
-19.42%
-51.26%
+206.35%
+208.8%
+62.18%
+34.49%
-73.59%
-85.37%
-92.14%
Bio Vitos Pharma operates in the medical technology industry. The company develops and commercializes products for the detection of hemolysis in blood samples. The company has developed products that ensure that the hemolysis is detected at an early stage, which means that the blood sample can be taken care of immediately. The company also develops digital reading that is used as a complement to the main product. Bio Vitos Pharma was founded in 2010 and is headquartered in Karlstad.
Read moreMarket cap
15.21M SEK
Turnover
116.71K SEK
Revenue
3M
EBIT %
-430.67 %
P/E
-
Dividend yield-%
-
Financial calendar
14/2
2025
Annual report '24
13/5
2025
Interim report Q1'25
14/5
2025
General meeting '24
ShowingAll content types
Bio Vitos Pharma AB: Sven Rohmann utses till ny tf VD
Bio Vitos Pharma AB: Bio Vitos ersätter befintlig kreditfacilitet med ny
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools